Introducing aiMOS: AI-Driven Media Optimization for Cell Therapy
Phacilitate
| 10 Feb 2026
GeminiBio and Tolemy Bio will introduce aiMOS™, an AI-driven media optimization service that helps teams reduce variability, increase performance, and improve manufacturability.
Join the industry in Barcelona | 7 - 9 September 2026 for 3 days of deal-making, data-driven insight and serious momentum across cell and gene therapy. From early science to commercial scale, this is where the full ecosystem connects, collaborates and moves the field forward.
